EPA Chief Warns States Over Emission Rules

Gina McCarthy, head of the US Environmental Protection Agency (EPA), has warned state governments that it will enforce regulations to slash carbon emissions from power plants even if they choose not to cooperate.

McCarthy criticized lawmakers such as Republican Senate majority leader Mitch McConnell, who have called on state officials to ignore federal deadlines to submit plans to comply with the agency's Clean Power Plan.

"The EPA is going to regulate. Mid-summer is when the Clean Power Plan is going to be finalized," McCarthy said, adding that the agency will force states that refuse to submit compliance strategies to adopt a federal implementation plan.

The EPA is expected to propose the federal implementation plan as a default for states this summer.

A dozen states, including Kentucky, West Virginia, Indiana and Wyoming, sued the EPA in August 2014, soon after it proposed its Clean Power Plan, on grounds that the agency's use of a certain section of the Clean Air Act was illegal.

A federal Circuit Court of Appeals in Washington DC will hear arguments in the case on Apr. 16.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.